4th Annual Symposium ― Mycobacteria 2026: Translating Biology into Cures

Tuberculosis (TB) and non-tuberculous mycobacteria (NTM) remain two of the world’s most urgent infectious disease challenges.

Tuberculosis (M. tuberculosis) still claims over 1.25 million lives annually, with 10.6 million new cases in 2023 alone. Following the COVID-19 pandemic, TB has once again become the leading infectious killer worldwide.

NTM pulmonary disease presents an even bleaker picture: treatments are long, toxic, poorly tolerated, and often unsuccessful.

For both TB and NTM lung disease, the obstacles are strikingly similar—high pill burden, prolonged treatment, limited efficacy, toxicity, drug–drug interactions, and rising resistance. The urgent need is clear: shorter, safer, more effective regimens.

About the Symposium

The 4th Annual Symposium “Mycobacteria 2026: Translating Biology into Cures” will bring together leading scientists, clinicians, and innovators from around the globe to share the latest breakthroughs in TB and NTM research and drug discovery.

This event is designed to:

• Showcase cutting-edge science and novel therapeutic strategies
• Foster open dialogue across academia, industry, and clinical research
• Engage early-career researchers and students in shaping the next generation of cures

Join us in Singapore for two days of inspiring talks, dynamic discussions, and new collaborations driving the field forward.

Organized by TELMabNet, an excellence cluster supported by the Singapore National Research Foundation.